Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-07-15
1980-01-08
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260410, 560121, 560231, 562503, 424311, 424317, 549 22, 549 39, 2603407, 2603409P, 2603409R, C07C17700, A61K 3119, A61K 31215
Patent
active
041827732
ABSTRACT:
What is disclosed are prostaglandin-analogous cyclopentane derivatives of the formula I ##STR1## wherein R.sup.1 is hydrogen or a linear or branched, saturated or unsaturated aliphatic or cycloaliphatic radical having from 1 to 8 carbon atoms, or an araliphatic radical having from 7 to 9 carbon atoms, or a physiologically tolerable metal, NH.sub.4 or substituted ammonium ion derived from a primary, secondary or tertiary amine;
REFERENCES:
patent: 4024181 (1977-05-01), Babej et al.
Bartmann Wilhelm
Beck Gerhard
Lerch Ulrich
Scholkens Bernward
Teufel Hermann
Gerstl Robert
Hoechst Aktiengesellschaft
LandOfFree
Novel prostaglandin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel prostaglandin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel prostaglandin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1941142